Participant flow

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) · Source last updated 2025-08-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Participants received 1 mg/kg E-602 monotherapy administered weekly via IV infusion.

   id

   FG000

   title

   E-602 1 mg/kg

2. description

   Participants received 3 mg/kg E-602 monotherapy administered weekly via IV infusion.

   id

   FG001

   title

   E-602 3 mg/kg

3. description

   Participants received 10 mg/kg E-602 monotherapy administered weekly via IV infusion.

   id

   FG002

   title

   E-602 10 mg/kg

4. description

   Participants received 20 mg/kg E-602 monotherapy administered weekly via IV infusion.

   id

   FG003

   title

   E-602 20 mg/kg

5. description

   Participants received 30 mg/kg E-602 monotherapy administered weekly via IV infusion.

   id

   FG004

   title

   E-602 30 mg/kg

6. description

   Participants received 20 mg/kg E-602 monotherapy administered weekly via IV infusion. They also received 350 mg cemiplimab administered every 3 weeks via IV infusion.

   id

   FG005

   title

   E-602 20 mg/kg in Combination With Cemiplimab

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         5

      2. group Id

         FG001

         num Subjects

         4

      3. group Id

         FG002

         num Subjects

         9

      4. group Id

         FG003

         num Subjects

         15

      5. group Id

         FG004

         num Subjects

         15

      6. group Id

         FG005

         num Subjects

         21

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         5

      2. group Id

         FG001

         num Subjects

         4

      3. group Id

         FG002

         num Subjects

         9

      4. group Id

         FG003

         num Subjects

         15

      5. group Id

         FG004

         num Subjects

         15

      6. group Id

         FG005

         num Subjects

         21

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      4. group Id

         FG003

         num Subjects

         0

      5. group Id

         FG004

         num Subjects

         0

      6. group Id

         FG005

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice